VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab

doi:10.3748/wjg.14.4156

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4520)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

437

HTML

3657

Figures (1-4)

241

Tables (1-2)

185

Sum=4520

Jul 14, 2008 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (31)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Jul 14, 2008; 14(26): 4156-4167
Published online Jul 14, 2008. doi: 10.3748/wjg.14.4156

Full Size Figure Download Figure

Figure 4 Effect of cetuximab on (A) the expression of VEGF-D and VEGFR3 in SW480 cells cultured in the presence and absence of EGF and (B) the in vivo levels of VEGF-D and VEGFR3 in a NOD/SCID mouse xenograft model.

Citation: Moehler M, Frings C, Mueller A, Gockel I, Schimanski CC, Biesterfeld S, Galle PR, Holtmann MH. VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab. World J Gastroenterol 2008; 14(26): 4156-4167
URL: https://www.wjgnet.com/1007-9327/full/v14/i26/4156.htm
DOI: https://dx.doi.org/10.3748/wjg.14.4156